Manufacturer record
Dr. Edwin Medilabs Pvt.Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Dr. Edwin Medilabs Pvt.Ltd (Punjab) were declared Not of Standard Quality between April 2024 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: DEMT-250831B, Telmisartan 40 mg tablets I.P. (exp Mar 2027). State Lab, DCL, Telangana (state lab) found it not of standard quality: Sample Does not meets the Specifications wrt. Uniformity of weight as per IP. Listed in the August 2026 alert.
Records by type
7 records linked to Dr. Edwin Medilabs Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan 40 mg tablets I.P. | Batch DEMT-250831BMfg Apr 2025 · Exp Mar 2027 | Sample Does not meets the Specifications wrt. Uniformity of weight as per IPUniformity of weight/content | State Lab, DCL, TelanganaState lab | Aug 2026 |
| Amoxycillin & Potassium Clavulanate Tablets IP | Batch DBT-2508AMfg Nov 2025 · Exp Apr 2026 | Asay and DissolutionDissolution | DCL, TelanganaState lab | Sep 2025 |
| FT-Prime625 Tablets, Amoxycillin & Potassium Clavulanate Tablets I.P | Batch BT-00744Mfg Jun 2024 · Exp Nov 2025 | Sample does not comply Uniformity of weight, Assay and Dissolution for Clavulanic acid as per IP 2022.Assay | State Lab, Drugs Control Laboratory, TelanganaState lab | Jul 2025 |
| Coxmyth-90 Tablets, (Etoricoxib Tablets IP 90mg) | Batch DEMT- 242366BMfg Nov 2024 · Exp Oct 2026 | Uniformity of Weight and Dissolution Test for EtoricoxibDissolution | State Lab KarnatakaState lab | Jun 2025 |
| Ceaxil -500 Tablets, Cefuroxime Axetil Tablets IP | Batch BT-227375Mfg Jan 2024 · Exp Dec 2025 | White coloured, elongated, biconvex tablets with score on one side, and plain on other side, 10 out of 50 tablets have brown- coloured spots on the entire surface. Hence, the tablets failed the test for Description of tablets.Description | State Lab Drugs Control Laboratory, TelanganaState lab | Dec 2024 |
| Atovaris-F | Batch DEMT- 240124BMfg Apr 2024 · Exp Mar 2026 | Sample does not conform to IP Specification with respect to Uniformity of Weight.Uniformity of weight/content | DTL MaduraiState lab | Dec 2024 |
| Promethazine Hydrochloride Syrup IP (Phena Kid Syrup) | Batch DEML- 304269Mfg Feb 2023 · Exp Jan 2025 | AssayAssay | CDL KolkataCDSCO lab | Apr 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.